Company Filing History:
Years Active: 2012-2018
Title: Erkki Savilahti: Innovator in Genetic Research
Introduction
Erkki Savilahti is a notable inventor based in Hus, Finland. He has made significant contributions to the field of genetic research, particularly in understanding adult-type hypolactasia. With a total of 2 patents, his work has implications for both diagnostics and treatment in this area.
Latest Patents
Savilahti's latest patents focus on the identification of a DNA variant associated with adult-type hypolactasia. The first patent describes a nucleic acid molecule that comprises a 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene. This gene is indicative of adult-type hypolactasia. The invention also includes methods for testing for the presence of or predisposition to this condition, based on the analysis of a single nucleotide polymorphism (SNP) contained in the nucleic acid molecule. Additionally, the patent outlines a diagnostic composition and kit useful for detecting the presence of or predisposition to adult-type hypolactasia.
Career Highlights
Erkki Savilahti is affiliated with the National Public Health Institute, where he continues to advance research in genetics. His work has been instrumental in enhancing the understanding of lactose intolerance and its genetic basis.
Collaborations
Savilahti has collaborated with esteemed colleagues such as Leena Peltonen and Nabil Enattah. Their joint efforts have contributed to the advancement of knowledge in genetic research and diagnostics.
Conclusion
Erkki Savilahti's innovative work in genetic research, particularly regarding adult-type hypolactasia, showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving diagnostic methods and understanding genetic predispositions.